What is Pifeltro (doravirine) for?
Buy Pifeltro (doravirine). Pifeltro (doravirine) is a medicine for adults with HIV-1 infection. It’s used with other HIV medicines.
It’s not for people with HIV who are resistant to certain medicines.
It comes in a tablet form with 100 mg doravirine in each.
How does Pifeltro (doravirine) work?
Doravirine in Pifeltro blocks a virus enzyme called reverse transcriptase (RT). This action reduces HIV particles in the blood.
It can’t cure HIV or AIDS but helps the immune system recover and prevent damage.
Where has Pifeltro (doravirine) been approved?
Pifeltro (doravirine) is approved for HIV-1 treatment by:
- Food and Drug Administration (FDA), USA on August 30, 2018.
- European Medicines Agency (EMA) on November 22, 2018.
- Therapeutic Goods Administration (TGA), Australia on January 18, 2019.
- Health Canada on November 18, 2019.
This medicine might be approved in other places too. If you have questions, contact our support team.
How is Pifeltro (doravirine) taken?
The usual dose is:
- One 100-mg tablet daily, with or without food.
- Take two tablets a day if you’re also on rifabutin, spaced 12 hours apart.
Warning: Don’t take Pifeltro with strong CYP3A enzyme inducers. They can make it less effective.1
For more details on dosage and use, see the official prescribing information.1
Note: Always talk to your doctor about the right dosage for you.
Are there any known adverse reactions or side effects of Pifeltro (doravirine)?
Common adverse reactions
Common side effects (≥5% of patients) include:
- Nausea
- Dizziness
- Headache
- Tiredness
- Diarrhea
- Stomach pain
- Abnormal dreams
Serious adverse reactions
Severe side effects include:
- Immune Reconstitution Syndrome
What conditions can RoActemra treat?
RoActemra is primarily indicated for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, and giant cell arteritis. It has also shown promising results in the treatment of cytokine release syndrome, a potentially life-threatening complication of certain cancer immunotherapies. Additionally, RoActemra is being investigated for its potential in the treatment of COVID-19, due to its ability to mitigate the inflammatory response associated with severe cases of the disease.
What are the common side effects of RoActemra?
As with any medication, RoActemra is associated with a number of potential side effects. The most common side effects include infusion reactions, upper respiratory tract infections, and elevations in liver enzymes. In rare cases, RoActemra may also increase the risk of serious infections, such as pneumonia or sepsis. It is important to discuss the potential risks and benefits of RoActemra with your healthcare provider before starting treatment.
Is RoActemra right for me?
Deciding if RoActemra is right for you depends on several things. These include your health condition, medical history, and what you hope to achieve with treatment. Your doctor will help you create a plan that fits your needs and goals for health.
In conclusion, RoActemra (tocilizumab) is a groundbreaking drug. It could greatly improve the lives of people with autoimmune diseases. If you’re thinking about RoActemra, talk to your doctor to see if it’s the best choice for you.
Remember, your health is the most important thing. It’s crucial to take care of it. By being informed and proactive about your treatment, you can manage your health and live your best life.
Use in a specific population
It’s not known if Pifeltro can harm an unborn baby. Tell your doctor if you’re pregnant or planning to be.
Women with HIV should not breastfeed. The virus can pass to the baby through breast milk. It’s also unknown if the medicine can pass through breast milk and harm the baby.
For a full list of side effects and reactions, see the official prescribing information.